Cargando…
Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503057/ https://www.ncbi.nlm.nih.gov/pubmed/32971043 http://dx.doi.org/10.1016/S0140-6736(20)31970-X |
| _version_ | 1783584319409750016 |
|---|---|
| author | Logunov, Denis Y Dolzhikova, Inna V Tukhvatullin, Amir I Shcheblyakov, Dmitry V |
| author_facet | Logunov, Denis Y Dolzhikova, Inna V Tukhvatullin, Amir I Shcheblyakov, Dmitry V |
| author_sort | Logunov, Denis Y |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7503057 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75030572020-09-21 Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply Logunov, Denis Y Dolzhikova, Inna V Tukhvatullin, Amir I Shcheblyakov, Dmitry V Lancet Correspondence Elsevier Ltd. 2020 2020-09-21 /pmc/articles/PMC7503057/ /pubmed/32971043 http://dx.doi.org/10.1016/S0140-6736(20)31970-X Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Logunov, Denis Y Dolzhikova, Inna V Tukhvatullin, Amir I Shcheblyakov, Dmitry V Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply |
| title | Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply |
| title_full | Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply |
| title_fullStr | Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply |
| title_full_unstemmed | Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply |
| title_short | Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply |
| title_sort | safety and efficacy of the russian covid-19 vaccine: more information needed – authors’ reply |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503057/ https://www.ncbi.nlm.nih.gov/pubmed/32971043 http://dx.doi.org/10.1016/S0140-6736(20)31970-X |
| work_keys_str_mv | AT logunovdenisy safetyandefficacyoftherussiancovid19vaccinemoreinformationneededauthorsreply AT dolzhikovainnav safetyandefficacyoftherussiancovid19vaccinemoreinformationneededauthorsreply AT tukhvatullinamiri safetyandefficacyoftherussiancovid19vaccinemoreinformationneededauthorsreply AT shcheblyakovdmitryv safetyandefficacyoftherussiancovid19vaccinemoreinformationneededauthorsreply |